PAGANI, LISA
 Distribuzione geografica
Continente #
AS - Asia 3.291
NA - Nord America 2.594
EU - Europa 2.440
SA - Sud America 430
AF - Africa 73
OC - Oceania 17
Totale 8.845
Nazione #
US - Stati Uniti d'America 2.474
IT - Italia 972
SG - Singapore 956
VN - Vietnam 744
CN - Cina 652
HK - Hong Kong 412
RU - Federazione Russa 331
BR - Brasile 329
DE - Germania 287
IE - Irlanda 151
FR - Francia 137
GB - Regno Unito 114
SE - Svezia 105
KR - Corea 87
IN - India 84
CA - Canada 64
NL - Olanda 62
ES - Italia 57
ID - Indonesia 56
FI - Finlandia 54
BD - Bangladesh 42
AT - Austria 41
JP - Giappone 39
ZA - Sudafrica 34
MX - Messico 32
AR - Argentina 31
TR - Turchia 30
IQ - Iraq 29
PL - Polonia 28
CH - Svizzera 25
SA - Arabia Saudita 23
PH - Filippine 22
PK - Pakistan 21
EC - Ecuador 19
AU - Australia 17
IR - Iran 17
VE - Venezuela 14
CO - Colombia 13
LT - Lituania 13
UZ - Uzbekistan 13
UA - Ucraina 12
BE - Belgio 10
TW - Taiwan 10
MA - Marocco 9
CL - Cile 8
DK - Danimarca 8
CZ - Repubblica Ceca 7
EG - Egitto 7
MY - Malesia 6
PY - Paraguay 6
IL - Israele 5
KE - Kenya 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
JO - Giordania 4
LB - Libano 4
MN - Mongolia 4
MT - Malta 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
CR - Costa Rica 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
CU - Cuba 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
MZ - Mozambico 1
NI - Nicaragua 1
Totale 8.840
Città #
Singapore 583
Ashburn 418
Hong Kong 394
San Jose 366
Milan 322
Ho Chi Minh City 239
Hanoi 204
Dallas 170
Frankfurt am Main 170
Dublin 149
Hefei 148
Los Angeles 124
New York 112
Santa Clara 90
Ann Arbor 85
Chandler 85
Seoul 79
Beijing 71
Chicago 66
The Dalles 61
Munich 50
Shanghai 42
São Paulo 40
Jakarta 38
Buffalo 37
Lauterbourg 37
Da Nang 30
Moscow 30
Nuremberg 28
Rome 28
Kent 27
London 27
Helsinki 25
Tokyo 25
Florence 24
Montreal 23
Orem 23
Brooklyn 22
Denver 22
Council Bluffs 21
Haiphong 21
Amsterdam 20
Boston 20
Johannesburg 20
Hải Dương 19
Turku 19
Biên Hòa 18
Warsaw 18
Naples 17
Zurich 17
Can Tho 16
Madison 16
Sesto San Giovanni 15
Toronto 15
Vienna 15
Chennai 14
Genoa 14
Poplar 14
Baghdad 13
Cinisello Balsamo 13
Ha Long 13
Paris 13
Ripalta Cremasca 13
Tashkent 13
Ninh Bình 12
Phoenix 12
Seregno 12
Stockholm 12
Cagliari 11
Como 11
Houston 11
Monza 11
Quận Bình Thạnh 11
Rio de Janeiro 11
Riyadh 11
Romola 11
Turin 11
Bergamo 10
Pune 10
Ankara 9
Brussels 9
Carate Brianza 9
Lahore 9
Melzo 9
Mexico City 9
Thái Nguyên 9
Atlanta 8
Düsseldorf 8
Guayaquil 8
Lappeenranta 8
Manchester 8
Princeton 8
San Francisco 8
Terni 8
Vercelli 8
Wroclaw 8
Bexley 7
Brugine 7
Bắc Ninh 7
Cape Town 7
Totale 5.259
Nome #
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 549
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 390
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 364
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 345
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 329
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 305
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 283
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 281
A molecular imaging approach to individuate tumour infiltrating lymphocytes 280
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 278
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 276
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 266
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 262
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 262
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 255
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 246
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 246
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 239
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 238
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 234
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 229
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 228
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 224
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 221
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 203
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 182
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 181
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 179
Tailored proteomic approaches based on nano-Liquid Chromatography-Mass Spectrometry to address biomedical challenging issues 170
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 165
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 154
Proteomic and glycoproteomic approaches based on nLC-ESI MS/MS for exploring cancer matrisome: explorative study 153
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 146
Proteomic characterization and comparison of human platelet lysates for a standardized and high quality production 135
Proteomic monitoring by label-free nLC-MS/MS of human platelet lysates for a standardized and optimized production 127
Deep proteome investigation in clinical studies: from the method development to its application 110
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 77
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination 62
Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility/resilience in the hippocampus 58
N-Glycan profiling from DBS using the power of timsTOF fleX 46
Totale 8.978
Categoria #
all - tutte 26.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 8 30 21 19 0 9 7 7 24 30
2022/2023596 68 84 61 87 38 74 23 35 37 19 30 40
2023/2024733 19 22 27 84 64 188 114 39 50 16 35 75
2024/20252.259 72 169 142 111 218 106 158 72 234 387 215 375
2025/20265.235 958 396 492 699 457 295 829 177 365 503 64 0
Totale 8.978